Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Bristol Myers Squibb’s Opdualag fails to meet primary endpoint in Phase 3 trial
Bristol Myers Squibb has announced that its Phase 3 RELATIVITY-098 clinical trial, designed to evaluate Opdualag (nivolumab and…
Glenmark Pharmaceuticals posts strong Q3 FY2025 earnings as global expansion gains momentum
Glenmark Pharmaceuticals Limited has reported a strong financial performance for the third quarter of fiscal year 2025, driven…
Hanmi Pharmaceutical expands global reach with automated vial dispensing solution
Hanmi Pharmaceutical is making significant strides in the North American pharmaceutical industry with its latest innovation—Countmate, an automated…
New hope for asthma and eczema? Akeso’s latest antibody AK139 enters clinical trials
Akeso, Inc. (9926.HK) has announced a major milestone with the acceptance of its Investigational New Drug (IND) application…
Can Thykamine change the future of MASH treatment? Devonian Health Group says yes!
Devonian Health Group Inc. (TSXV: GSD; OTCQB: DVHGF), a clinical-stage pharmaceutical company, has announced promising preclinical results for…
Moleculin Biotech moves forward with pivotal Annamycin trial in AML after FDA backing
Moleculin Biotech, Inc. (Nasdaq: MBRX), a late-stage pharmaceutical company focused on developing innovative treatments for acute myeloid leukemia,…
Scientists investigate NPRL2 gene therapy for hard-to-treat lung cancer—What they found
A significant study published in eLife suggests that NPRL2 gene therapy could offer a new therapeutic approach for…
Edesa Biotech raises capital to advance CXCL10 antibody program
Edesa Biotech, Inc. has successfully raised $15 million through a private placement offering, a critical move that will…
Akeso begins Phase 3 trial of cadonilimab as consolidation therapy for non-small cell lung cancer
Akeso, Inc. (9926.HK) has initiated its pivotal Phase 3 cadonilimab trial for non-small cell lung cancer (NSCLC), marking…
Pfizer’s ADCETRIS combination regimen secures FDA approval for relapsed large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc.’s supplemental Biologics License Application (sBLA) for ADCETRIS…